Cannabidiol shows promise in treating cognitive disorders

Research reviews the therapeutic potential of cannabidiol (CBD) in treating cognitive impairments, highlighting positive effects in some trials while emphasizing the need for more comprehensive studies.

Vaccinex plans Nasdaq exit as Alzheimer market pressure grows – Pharmaceutical Technology

Vaccinex’s lead asset is being evaluated in neurodegenerative and oncological indications. Image credit: Shutterstock/interstid. Despite reporting positive Phase II results for its lead candidate last

March 10, 2025

What are the differences in risks of adverse pregnancy outcomes based on the level of pre-pregnancy specialist mental health care?

The evidence on the effects of maternal mental health illnesses on increased risk of adverse obstetric and neonatal outcomes.

August 18, 2023

Study finds specific gut microbiota signature is associated with vulnerability to food addiction

Researchers of a recent study published in Gut explored gut microbial involvement in food addiction-related processes.

July 1, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.